RESUMEN
BACKGROUND: Emergency contraception reduces the risk of unintended pregnancy, after unprotected sexual intercourse or contraceptive failure. In Belgium, emergency contraception is available without a prescription and pharmacists play therefore a crucial role in dispensing emergency contraception. AIM: This study assesses the dispensing practices of emergency contraception by pharmacists in two regions of Belgium. METHOD AND DESIGN: Simulated patient study, using a predefined scenario, evaluating a request for emergency contraception. The scenario involves a 25-year-old woman not using contraception, who had unprotected sexual intercourse 84 h (3.5 days) ago. Her last menstrual period was 10 days ago. POPULATION: 260 pharmacies were randomly selected. Principal outcome: proportion of pharmacists who deliver the adequate emergency contraception. We considered the following responses as adequate: Prescribing ulipristal acetate or redirecting to another pharmacy, in case of unavailability, or referring for a copper IUD. RESULTS: We analysed the data obtained in 216 pharmacies (216/260 = 83.1%). In 64% of cases, adequate dispensing of emergency contraception (dispensing of ulipristal acetate or referral for intrauterine device insertion) occurred. There was an association between correct dispensing and asking appropriate questions, such as the date of the last menstrual period and the date of the risky sexual intercourse. CONCLUSION: More than one-third of visited pharmacies did not distribute appropriate emergency contraception, underlining the need for improvement. We hypothesise that this may be achieved with appropriate training, use a dispensing checklist.
We assesses the dispensing of emergency contraception by pharmacists using a simulated patient. More than one-third of visited pharmacies did not distribute appropriate emergency contraception, underlining the need for improvement.
Asunto(s)
Anticoncepción Postcoital , Norpregnadienos , Simulación de Paciente , Farmacéuticos , Humanos , Femenino , Bélgica , Anticoncepción Postcoital/estadística & datos numéricos , Adulto , Norpregnadienos/uso terapéutico , Pautas de la Práctica Farmacéutica/estadística & datos numéricos , Dispositivos Intrauterinos de Cobre/estadística & datos numéricos , Anticonceptivos Poscoito/uso terapéutico , EmbarazoRESUMEN
OBJECTIVE: To examine the prevalence of infections with high-risk human papillomavirus (HPV) and cervical dysplasia, and the clearance rate of HPV infections, in users of different kinds of intrauterine devices (IUDs) and other contraceptive methods. METHODS: A cross-sectional register-based study including 16,181 women aged 30-49 years participating in the screening programme for cervical cancer in a Swedish County in 2017-2018. Data on contraception from screening records was paired with the HPV test results, cytological and histological follow-up tests and subsequent HPV test. RESULTS: There was no difference in the risk of being HPV positive, or histological HSIL+, between users of copper-containing IUDs and women with no reported use of contraception. Use of levonorgestrel intrauterine system and hormonal contraception were associated with higher odds for HPV infection in age-adjusted models (aOR 1.21; 95% CI 1.04-1.41, and aOR 1.41; 95% CI 1.22-1.63, respectively) and for HSIL+ (aOR 1.45; 95% CI 1.02-2.06, and aOR 1.56; 95% CI 1.13-2.16, respectively). No significant differences were found in HPV clearance rates. CONCLUSIONS: Reported use of levonorgestrel intrauterine system and hormonal contraception, but not use of copper IUD, was associated with a higher prevalence of HPV infections and histological HSIL + compared to no reported use of contraception.
Women using copper IUD showed no difference in prevalence of HPV or cervical dysplasia compared to women not using contraception in cross-sectional study.
Asunto(s)
Dispositivos Intrauterinos , Infecciones por Papillomavirus , Displasia del Cuello del Útero , Humanos , Femenino , Estudios Transversales , Adulto , Infecciones por Papillomavirus/epidemiología , Persona de Mediana Edad , Prevalencia , Displasia del Cuello del Útero/epidemiología , Suecia/epidemiología , Dispositivos Intrauterinos/efectos adversos , Dispositivos Intrauterinos/estadística & datos numéricos , Levonorgestrel , Dispositivos Intrauterinos de Cobre/efectos adversos , Dispositivos Intrauterinos de Cobre/estadística & datos numéricos , Neoplasias del Cuello Uterino/epidemiología , Anticoncepción/estadística & datos numéricos , Anticoncepción/métodos , Dispositivos Intrauterinos Medicados/efectos adversosRESUMEN
BACKGROUND: Despite the positive characteristics of the levonorgestrel-releasing intrauterine device (IUD)-a long-acting, highly effective contraceptive with important non-contraceptive attributes-the method has not been widely available in low- and middle-income countries. This study of hormonal IUD, copper IUD, implant and injectable users in Nigeria compares their characteristics, reasons for method choice, and experiences obtaining their method. METHODS: We conducted a phone survey with 888 women who received a hormonal IUD, copper IUD, contraceptive implant or injectable from 40 social franchise clinics across 18 states in Nigeria. We analyzed survey data descriptively by method and assessed factors associated with hormonal IUD use through multivariate logistic regression models. Follow-up in-depth interviews conducted with 32 women were analyzed thematically. RESULTS: There were few differences by method used in the socio-demographic profiles and contraceptive history of participants. Among users choosing a long-acting, reversible method, the top reasons for method choice included perceptions that the method was "right for my body," long duration, recommended by provider, recommended by friends/family, few or manageable side effects, and high effectiveness. Among hormonal IUD users, 17% mentioned reduced bleeding (inclusive of lighter, shorter, or no period), and 16% mentioned treatment of heavy or painful periods. Qualitative data supported these findings. Among survey respondents, between 25% and 33% said they would have chosen no method if the method they received had not been available. Both quantitative and qualitative data indicated that partner support can affect contraceptive use, with in-depth interviews revealing that women typically needed partner permission to use contraception, but men were less influential in method choice. CONCLUSIONS: Expanding access to the hormonal IUD as part of a full method mix provides an opportunity to expand contraceptive choice for women in Nigeria. Findings are timely as the government is poised to introduce the method on a wider scale.
Asunto(s)
Anticoncepción/instrumentación , Anticonceptivos Femeninos/administración & dosificación , Implantes de Medicamentos/administración & dosificación , Levonorgestrel/administración & dosificación , Adulto , Anticoncepción/psicología , Femenino , Humanos , Inyecciones , Dispositivos Intrauterinos de Cobre/estadística & datos numéricos , Persona de Mediana Edad , Nigeria , Estudios Prospectivos , Encuestas y Cuestionarios , Adulto JovenAsunto(s)
Dispositivos Intrauterinos de Cobre/estadística & datos numéricos , Enfermedades de Transmisión Sexual/epidemiología , Adolescente , Adulto , Femenino , Humanos , Incidencia , Dispositivos Intrauterinos Medicados/estadística & datos numéricos , Persona de Mediana Edad , Estados Unidos , Adulto JovenAsunto(s)
Anticonceptivos Femeninos/administración & dosificación , Implantes de Medicamentos , Dispositivos Intrauterinos Medicados/estadística & datos numéricos , Acetato de Medroxiprogesterona/administración & dosificación , Embarazo Ectópico/epidemiología , Estudios de Cohortes , Anticonceptivos Femeninos/uso terapéutico , Dispositivos Anticonceptivos Femeninos , Anticonceptivos Orales/uso terapéutico , Preparaciones de Acción Retardada , Femenino , Humanos , Dispositivos Intrauterinos de Cobre/estadística & datos numéricos , Levonorgestrel/administración & dosificación , Levonorgestrel/uso terapéutico , Acetato de Medroxiprogesterona/uso terapéutico , Embarazo , Modelos de Riesgos Proporcionales , Estudios Prospectivos , Parche TransdérmicoRESUMEN
OBJECTIVE: We evaluated clinical performance when the TCu380A intrauterine device (IUD) and the levonorgestrel (LNG) 52-mg intrauterine system (IUS) were inserted by different categories of healthcare professionals. METHODS: A retrospective study was conducted at the University of Campinas, Brazil. The medical records were reviewed of all women in whom an IUD was inserted between January 1980 and December 2018, with data for at least 1 year, and for whom information on the healthcare provider who inserted the device was available. RESULTS: Overall, 19 132 (76.9%) IUD and 5733 (23.1%) LNG-IUS insertions were included, with residents/interns performing 13 853 (55.8%), nurses 7024 (28.2%), and physicians 3988 (16.0%). Removals for pregnancy and infection were significantly higher when physicians inserted the device, while removals for bleeding/pain and other medical reasons were more common when nurses performed the insertion. Expulsion and removals for personal reasons were similar for all three categories. CONCLUSION: Clinical outcomes were similar regardless of whether trained nurses, residents/interns, or physicians inserted the device, and were irrespective of users' age and parity. These results could stimulate other healthcare services, particularly in regions where there is a shortage of physicians, to invest in training nurses to perform insertions of IUDs.
Asunto(s)
Personal de Salud/estadística & datos numéricos , Dispositivos Intrauterinos de Cobre/estadística & datos numéricos , Dispositivos Intrauterinos Medicados/estadística & datos numéricos , Levonorgestrel/administración & dosificación , Adolescente , Adulto , Brasil , Niño , Anticonceptivos Femeninos/administración & dosificación , Atención a la Salud , Femenino , Hemorragia/epidemiología , Humanos , Embarazo , Estudios Retrospectivos , Adulto JovenRESUMEN
PURPOSE: This prospective cross-sectional study aimed to compare uterine and ovarian arterial Doppler signals in regularly menstruating patients who had been using copper intrauterine devices (IUD) for different durations. METHODS: Four groups of participants were formed (n = 30 for each) depending on the duration of copper IUD use: less than 1 year (group 1), 1 to 3 years (group 2), and over 3 years (group 3). Women without IUDs formed the control group. All participants were called in on the fifth-eighth days of their menstrual cycle for Doppler blood flow assessment. The pulsatility index (PI) and resistance index (RI) values were recorded in uterine and ovarian arteries. RESULTS: The groups 2 and 3 had significantly higher uterine artery PI and RI values than groups 1 and 4. Furthermore, group 2 had uterine and ovarian artery PI and RI values similar to those of group 3. There was a positive relationship between uterine and ovarian arteries' PI and RI values with the duration of IUD use. CONCLUSIONS: The presence of an IUD for over a year seems to cause changes in the uterine artery PI and RI values assessed by Doppler ultrasonography.
Asunto(s)
Dispositivos Intrauterinos de Cobre/estadística & datos numéricos , Ovario/irrigación sanguínea , Flujo Sanguíneo Regional , Útero/irrigación sanguínea , Adulto , Estudios Transversales , Femenino , Humanos , Estudios Prospectivos , Factores de Tiempo , Ultrasonografía Doppler en ColorRESUMEN
OBJECTIVE: The aim of the study was to compare 6 month expulsion rates of the copper-bearing intrauterine device (IUD) inserted after delivery of the placenta or at the 6 week postpartum visit in women undergoing caesarean section. METHODS: A parallel-group randomised trial was conducted in an Egyptian university hospital between February 2016 and December 2018. Participants were randomised to either post-placental IUD insertion or IUD insertion at the 6 week postpartum visit. Participants were followed for 12 months. Primary outcomes were IUD expulsion and the proportion of women using an IUD at 6 months. A secondary outcome was the cumulative pregnancy rate at 12 months. RESULTS: Five hundred participants were enrolled in each group. At 6 months the total expulsions were 58/416 (13.9%) in the post-placental group and 4/214 (1.9%) in the puerperal group; IUD use at 6 months was 416/478 (87.0%) in the post-placental group and 214/232 (92.2%) in the puerperal group. Data collected by phone at 12 months showed a higher cumulative pregnancy rate in the puerperal group (84/500, 16.8%) vs the post-placental group (22/500, 4.4%). IUD continuation at 12 months was higher in the post-placental group. CONCLUSION: Participants in the post-placental group had a higher expulsion rate at 6 months, but more IUDs were placed in this group and fewer pregnancies had occurred at 12 months compared with the puerperal group. TRIAL REGISTRATION: Clinicaltrials.gov NCT02679820.
Asunto(s)
Anticoncepción/efectos adversos , Anticoncepción/métodos , Expulsión de Dispositivo Intrauterino/efectos adversos , Dispositivos Intrauterinos de Cobre/efectos adversos , Dispositivos Intrauterinos de Cobre/estadística & datos numéricos , Índice de Embarazo , Adulto , Cesárea , Anticoncepción/estadística & datos numéricos , Egipto , Femenino , Humanos , Persona de Mediana Edad , Placenta , Periodo Posparto , Embarazo , Adulto JovenRESUMEN
BACKGROUND: Since 2013, the residents of the city of Vantaa, Finland, have been offered their first long-acting reversible contraceptive method (levonorgestrel-releasing intrauterine system, implant, and copper intrauterine device) free of charge. OBJECTIVE: The primary aim of this study was to assess the 2-year cumulative discontinuation rates of long-acting reversible contraceptive methods when provided free of charge for first-time users in a real-world setting. Additional aims were to describe factors associated with discontinuation and to evaluate the reasons for discontinuation. STUDY DESIGN: This is a retrospective register-based cohort study of 2026 nonsterilized women aged 15 to 44 years, who initiated a free-of-charge long-acting contraceptive method in 2013-2014 in the city of Vantaa. Removals within 2 years after method initiation and reasons for discontinuation were obtained from electronic health records and from national registers. We calculated the 2-year cumulative incidence rates of discontinuation with 95% confidence intervals for each method. Furthermore, we assessed crude and adjusted incidence rate ratios of discontinuation with 95% confidence interval by Poisson regression models comparing implants and copper intrauterine device with levonorgestrel-releasing intrauterine systems. RESULTS: During the 2 -year follow-up, 514 women discontinued, yielding a cumulative discontinuation rate of 28.3 per 100 women-years (95% confidence interval, 26.2-30.4). Among the 1199 women who initiated the levonorgestrel-releasing intrauterine system, the cumulative discontinuation rate was 24.2 per 100 women-years (95% confidence interval, 21.7-26.9); among the 642 implant users, 33.3 per 100 women-years (95% confidence interval, 29.5-37.4); and among the 185 copper intrauterine device users, 37.8 per 100 women-years (95% confidence interval, 31.0-45.7). Compared with women aged 30 to 44 years, women aged 15 to 19 years (adjusted incidence rate ratio, 1.58; 95% confidence interval, 1.17-2.14) and 20 to 29 years (adjusted incidence rate ratio, 1.35; 95% confidence interval, 1.11-1.63) were more likely to discontinue. We observed a higher discontinuation rate in women who had given birth within the previous year (adjusted incidence rate ratio, 1.36; 95% confidence interval, 1.13-1.65), spoke a native language other than Finnish or Swedish (adjusted incidence rate ratio, 1.31; 95% confidence interval, 1.06-1.63), and had a history of a sexually transmitted infection (adjusted incidence rate ratio, 1.62; 95% confidence interval, 1.07-2.46). No association was found in marital status, overall parity, history of induced abortion, socioeconomic status, education level, or smoking status. The most common reason for discontinuation was bleeding disturbances, reported by 21% of women who discontinued the levonorgestrel-releasing intrauterine system, by 71% who discontinued the implant, and by 41% who discontinued the copper intrauterine device. One in 4 women who discontinued the copper intrauterine device reported heavy menstrual bleeding, whereas only 1% who discontinued the levonorgestrel-releasing intrauterine system and none who discontinued implants reported this reason. Abdominal pain was the reported reason for discontinuation in 20% of both intrauterine device users and in only 2% who discontinued implants. CONCLUSION: At 2 years, the use of implants and copper intrauterine devices was more likely to be discontinued than that of the levonorgestrel-releasing intrauterine system. Women younger than 30 years and those who gave birth in the preceding year, spoke a native language other than Finnish or Swedish, or had a history of sexually transmitted infections were more likely to discontinue. The levonorgestrel-releasing intrauterine system was least likely to be removed owing to bleeding disturbances.
Asunto(s)
Anticonceptivos Femeninos/administración & dosificación , Remoción de Dispositivos/estadística & datos numéricos , Dispositivos Intrauterinos de Cobre/estadística & datos numéricos , Dispositivos Intrauterinos Medicados/estadística & datos numéricos , Aborto Inducido , Adolescente , Adulto , Factores de Edad , Estudios de Cohortes , Implantes de Medicamentos/economía , Implantes de Medicamentos/uso terapéutico , Escolaridad , Femenino , Financiación Gubernamental , Finlandia/epidemiología , Humanos , Dispositivos Intrauterinos de Cobre/economía , Dispositivos Intrauterinos Medicados/economía , Levonorgestrel/administración & dosificación , Anticoncepción Reversible de Larga Duración/economía , Anticoncepción Reversible de Larga Duración/estadística & datos numéricos , Estado Civil , Trastornos de la Menstruación/inducido químicamente , Paridad , Estudios Retrospectivos , Fumar/epidemiología , Clase Social , Adulto JovenRESUMEN
Limited data exist on the effects of contraceptives on HIV disease progression. We studied the association between intramuscular injectable depot medroxyprogesterone acetate (DMPA-IM), the copper intrauterine device (IUD), and the levonorgestrel (LNG) implant on markers of HIV disease progression at the time of HIV detection and 3 months postdetection and time from detection to CD4 count <350 cells/mm3. Among women initiating antiretroviral therapy (ART), we studied the effect of contraceptive group on time from ART initiation to viral load (VL) <40 copies/mL. We included women 16-35 years randomized to DMPA-IM, copper IUD, or LNG implant with incident HIV infection during the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial (n = 382). We analyzed HIV VL and CD4 cell count according to participants' randomized method and also conducted a "continuous use" analysis that excluded follow-up time after method discontinuation. We used adjusted linear models to compare mean VL and CD4 cell levels by contraceptive group up to the time of ART initiation. We compared time from HIV detection to CD4 count <350 cells/mm3 and, following ART initiation, time to viral suppression (VL <40 copies/mL) using Cox proportional hazards models. At HIV detection, women allocated to DMPA-IM had lower VL relative to copper IUD (-0.28 log10 copies/mL; 95% confidence interval [CI]: -0.55 to -0.01) and LNG implant (-0.27, CI: -0.55 to 0.02) and higher mean CD4 than copper IUD users by 66 cells/mm3 (CI: 11-121). In continuous use analyses women allocated to DMPA-IM progressed to CD4 < 350 cells/mm3 slower than copper IUD users (hazard ratio [HR] = 0.6, CI: 0.3-1.1), whereas copper IUD users progressed faster than LNG implant users (HR = 1.8, CI: 1.0-3.3). Time to viral suppression was faster for DMPA-IM than copper IUD (HR = 1.5, CI: 1.0-2.3) and LNG implant 1.4 (CI: 0.9-2.2) users. We found no evidence of more rapid early HIV disease progression among women using DMPA-IM than among women using copper IUD or LNG implant. Our finding of more rapid progression among copper IUD compared with DMPA-IM users should be interpreted cautiously.
Asunto(s)
Infecciones por VIH/inmunología , Dispositivos Intrauterinos de Cobre/estadística & datos numéricos , Levonorgestrel/farmacología , Acetato de Medroxiprogesterona/administración & dosificación , Carga Viral/efectos de los fármacos , Adolescente , Adulto , Recuento de Linfocito CD4 , Progresión de la Enfermedad , Femenino , Infecciones por VIH/complicaciones , Infecciones por VIH/fisiopatología , Anticoncepción Hormonal , Humanos , Dispositivos Intrauterinos de Cobre/normas , Modelos de Riesgos Proporcionales , Adulto JovenRESUMEN
OBJECTIVE: To evaluate the delivery-to-insertion interval for copper postpartum intrauterine devices (PPIUDs). METHODS: Secondary analysis of two related studies at five academic sites in India from March 2015 to July 2016. IUDs were inserted within 48 hours of vaginal delivery. Women (n=560) were grouped by whether they underwent postplacental (≤10 minutes) or immediate (>10 minutes) insertion. Outcomes were complete expulsion at the 6-8-week follow-up (primary), and IUD-to-fundus distance, as assessed by postinsertion ultrasound (secondary). RESULTS: Overall, 93 (16.6%) women received a postplacental PPIUD and 467 (83.4%) received an immediate PPIUD. Complete expulsion at follow-up was 3.2% (n=3) in the postplacental and 7.5% (n=35) in the immediate postpartum group (P=0.176; difference in proportions, 4.3%; 95% confidence interval, -2.0 to 8.1). Distance from the fundus did not differ between the two groups (P=0.107); high fundal placement (≤10 mm from the internal endometrial verge) was achieved for most women. CONCLUSION: The present data challenge previous guidance on the timing of PPIUD insertion. The 10-minute insertion window is a barrier to uptake and should be reassessed for inclusion in service delivery guidelines. A flexible interval would accommodate the multiple post-delivery tasks of providers and increase access to PPIUD.
Asunto(s)
Parto Obstétrico/estadística & datos numéricos , Expulsión de Dispositivo Intrauterino/etiología , Dispositivos Intrauterinos de Cobre/efectos adversos , Adulto , Femenino , Humanos , India , Dispositivos Intrauterinos de Cobre/estadística & datos numéricos , Persona de Mediana Edad , Periodo Posparto , Embarazo , Factores de TiempoRESUMEN
OBJECTIVE: To evaluate the relative risk of cervical neoplasms among copper intrauterine device (Cu IUD) and levonorgestrel-releasing intrauterine system (LNG-IUS) users. METHODS: We performed a retrospective cohort analysis of 10,674 patients who received IUDs at Columbia University Medical Center. Our data were transformed to a common data model and are part of the Observational Health Data Sciences and Informatics network. The cohort patients and outcomes were identified by a combination of procedure codes, condition codes, and medication exposures in billing and claims data. We adjusted for confounding with propensity score stratification and propensity score 1:1 matching. RESULTS: Before propensity score adjustment, the Cu IUD cohort included 8,274 patients and the LNG-IUS cohort included 2,400 patients. The median age for both cohorts was 29 years at IUD placement. More than 95% of the LNG-IUS cohort used a device with 52 mg LNG. Before propensity score adjustment, we identified 114 cervical neoplasm outcomes. Seventy-seven (0.9%) cervical neoplasms were in the Cu IUD cohort and 37 (1.5%) were in the LNG-IUS cohort. The propensity score matching analysis identified 7,114 Cu IUD and 2,174 LNG-IUS users, with covariate balance achieved over 16,827 covariates. The diagnosis of high-grade cervical neoplasia was 0.7% in the Cu IUD cohort and 1.8% in the LNG-IUS cohort (2.4 [95% CI 1.5-4.0] cases/1,000 person-years and 5.2 [95% CI 3.7-7.1] cases/1,000 person-years, respectively). The relative risk of high-grade cervical neoplasms among Cu IUD users was 0.38 (95% CI 0.16-0.78, P<.02) compared with LNG-IUS users. By inspection, the Kaplan-Meier curves for each cohort diverged over time. CONCLUSION: Copper IUD users have a lower risk of high-grade cervical neoplasms compared with LNG-IUS users. The relative risk of cervical neoplasms of LNG-IUS users compared with the general population is unknown.
Asunto(s)
Dispositivos Intrauterinos de Cobre/estadística & datos numéricos , Dispositivos Intrauterinos Medicados/estadística & datos numéricos , Levonorgestrel/administración & dosificación , Neoplasias del Cuello Uterino/epidemiología , Adolescente , Adulto , Niño , Anticonceptivos Femeninos/administración & dosificación , Bases de Datos Factuales , Femenino , Humanos , Dispositivos Intrauterinos de Cobre/efectos adversos , Dispositivos Intrauterinos Medicados/efectos adversos , Estimación de Kaplan-Meier , Persona de Mediana Edad , New York/epidemiología , Puntaje de Propensión , Estudios Retrospectivos , Medición de Riesgo , Adulto JovenRESUMEN
BACKGROUND: Few family-planning programs in Africa base demand creation and service delivery on theoretical models. Motivational interviewing is a counseling modality that facilitates reflection on the benefits and disadvantages of a health outcome to encourage behavior change. OBJECTIVES: We evaluate a couples-focused joint family-planning and HIV counseling intervention using motivational interviewing to enhance uptake of long-acting reversible contraception (Paragard copper intrauterine device or Jadelle hormonal implant) among Rwandan couples. STUDY DESIGN: In this experimental study, couples receiving care at 8 government health clinics in Kigali, the capital city, were referred from a parent study of couples who did not want more children or wanted to wait at least 2 years for their next pregnancy. Long-acting reversible contraception methods were offered on site following joint HIV testing and family-planning counseling. At the first follow-up visit 1 month after enrollment in the parent study, couples who had not yet chosen a long-acting reversible contraception method were interviewed separately using motivational interviewing and then brought together and again offered long-acting reversible contraception. RESULTS: Following motivational interviewing, 78 of 229 couples (34%) requested a long-acting reversible contraception method (68 implant and 10 intrauterine device). Long-acting reversible contraception uptake after motivational interviewing was associated with the woman being Catholic (vs Protestant/Muslim/other, adjusted odds ratio, 2.87, 95% confidence interval, 1.19-6.96, P = .019) or having an income (vs no income, adjusted odds ratio, 2.54, 95% confidence interval, 1.12-5.73, P = .025); the couple having previously discussed long-acting reversible contraception (adjusted odds ratio, 8.38, 95% confidence interval, 2.54-27.59, P = .0005); either partner believing that unplanned pregnancy was likely with their current method (adjusted odds ratio, 6.67, 95% confidence interval, 2.77-16.11, P < .0001); or that they might forget to take or make an appointment for their current method (adjusted odds ratio, 4.04, 95% confidence interval, 1.32-12.34, P = .014). Neither partner mentioning that condoms also prevent HIV/sexually transmitted infection was associated with long-acting reversible contraception uptake (adjusted odds ratio, 2.86, 95% confidence interval, 1.17-7.03, P = .022), as was the woman citing long-term duration of action of the implant as an advantage (adjusted odds ratio, 5.41, 95% confidence interval, 1.86-15.76, P = .002). The woman not listing any side effects or disadvantages of implants was associated with long-acting reversible contraception uptake (adjusted odds ratio, 5.42, 95% confidence interval, 2.33-12.59, P < .0001). Clinic location (rural vs urban), couple HIV status, and concerns about negative economic effects of an unplanned pregnancy were significant in bivariate but not multivariate analysis. CONCLUSION: Encouraging couples to reflect on the benefits and disadvantages of long-acting reversible contraception methods, the likelihood of unplanned pregnancy with their current contraception, and the impact of an unplanned pregnancy is an effective motivational interviewing technique in family-planning counseling. One third of couples who did not want a pregnancy for at least 2 years but had not chosen a long-acting reversible contraception method when provided with standard family-planning counseling did so after motivational interviewing. Involving the male partner in family-planning discussions facilitates joint decision making about fertility goals and contraceptive choice. Combining family planning and joint HIV testing for couples allows targeted focus on dual-method use with discordant couples, who are advised to use condoms for HIV/sexually transmitted infection prevention along with a more effective contraceptive for added protection against unplanned pregnancy.
Asunto(s)
Servicios de Planificación Familiar/métodos , Anticoncepción Reversible de Larga Duración/estadística & datos numéricos , Entrevista Motivacional/métodos , Esposos , Adulto , Catolicismo , Anticonceptivos Femeninos/administración & dosificación , Implantes de Medicamentos/uso terapéutico , Femenino , Infecciones por VIH/diagnóstico , Infecciones por VIH/prevención & control , Humanos , Renta/estadística & datos numéricos , Dispositivos Intrauterinos de Cobre/estadística & datos numéricos , Islamismo , Levonorgestrel/administración & dosificación , Masculino , Protestantismo , RwandaRESUMEN
Objective: The aim of the study was to assess the acceptability of the intrauterine ball IUB Ballerine MIDI copper intrauterine device (IUD), using real-world data collected from users and physicians in Israel.Methods: In this retrospective, observational study, conducted in a single clinic in Israel, healthy women (n = 175) who had had the device inserted ≥12 months prior to enrolment, and their physician, completed questionnaires relating to device insertion, user experience and performance.Results: The mean age at insertion was 32.8 ± 6.7 years; most women were married (80.6%) and multigravid (89.1%). At the time of the study, 131 (74.9%) women were still using the device; in 13 cases (7.4%), premature removal was due to desire to conceive. The 12 month continuation rate, excluding the women seeking to conceive, was 90.1%. The expulsion rate was 3.4% (n = 6) and the pregnancy rate was 0.57% (n = 1). Most of the women still using the device reported no to moderate pain or cramps (90.0%) and moderate to high (72.6%) satisfaction with the device; 76.3% said they would recommend it to friends and relatives. Most of the insertion procedures (86.9%) were uneventful and none required cervical dilation.Conclusion: The IUB Ballerine MIDI raised no major safety concerns and was both effective and highly accepted in a cohort of women, covering a broad age range, treated in a gynaecology clinic in Israel.
Asunto(s)
Dispositivos Intrauterinos de Cobre/estadística & datos numéricos , Aceptación de la Atención de Salud/estadística & datos numéricos , Adolescente , Adulto , Femenino , Humanos , Dispositivos Intrauterinos de Cobre/efectos adversos , Israel/epidemiología , Dolor/epidemiología , Dolor/etiología , Satisfacción del Paciente , Embarazo , Estudios Retrospectivos , Adulto JovenRESUMEN
INTRODUCTION: Expanding access to postpartum intrauterine contraception (PPIUC) can reduce unintended pregnancies and short inter-pregnancy intervals; however, provision across Europe is limited. Our aim was to determine the feasibility, clinical outcomes and patient satisfaction of providing immediate PPIUC after vaginal birth using a health services research model. MATERIAL AND METHODS: Phased introduction of PPIUC across two Lothian maternity hospitals; all women intending vaginal birth during the study period without a contraindication to use of the method were eligible to receive PPIUC. Midwives and obstetric doctors were trained in vaginal PPIUC insertion using Kelly forceps. Women received information antenatally and had PPIUC insertion of either a levonorgestrel intrauterine system or a copper intrauterine device within 48 hours of vaginal birth. Follow-up was conducted in-person at 6 weeks postpartum and by telephone at 3, 6 and 12 months. Primary outcomes were: uptake, complications (infection, uterine perforation), expulsion and patient satisfaction at 6 weeks; and method of continuation up to 12 months. Secondary outcomes included hazard ratio for expulsion adjusted for demographic and insertion-related variables. RESULTS: Uptake of PPIUC was 4.6% of all vaginal births; 465/447 (96.1%) of those requesting PPIUC successfully received it and most chose a levonorgestrel intrauterine system (73%). At 6 weeks postpartum, the infection rate was 0.8%, there were no perforations and 98.3% of women said they would recommend the service. The complete expulsion rate was 29.8% (n = 113) and most had symptoms (n = 79). Of the additional 121 devices removed, 118 were because of partial expulsion. The rate of complete/partial expulsion was higher for insertions by midwives compared with those by doctors. The re-insertion rate after expulsion/removal was 87.6% and method continuation at 12 months was 79.6%. CONCLUSIONS: Routine PPIUC at vaginal birth is feasible. Complications were extremely rare. High expulsion rates may be observed in early stages of service introduction and with inexperienced providers. Re-insertion and therefore longer-term continuation rates of intrauterine contraception were very high. In settings with low rates of attendance for interval postpartum intrauterine contraception insertion, PPIUC could be a useful intervention to prevent unintended and closely spaced pregnancies.
Asunto(s)
Anticoncepción/métodos , Dispositivos Intrauterinos de Cobre/estadística & datos numéricos , Dispositivos Intrauterinos Medicados/estadística & datos numéricos , Dispositivos Intrauterinos/estadística & datos numéricos , Satisfacción del Paciente/estadística & datos numéricos , Periodo Posparto , Adulto , Femenino , Humanos , Estudios Longitudinales , Reino UnidoRESUMEN
Background: To investigate the hypothesis that increased uptake of long-acting reversible contraception (LARC) by women played a role in the declining abortion rates observed in New Zealand between 2008 and 2014. Materials and Methods: This quantitative ecological study analyzed routinely collected national data pertaining to abortion numbers, contraceptive prescriptions, and census population estimates for the period 2004-2014. Annual prescription and prevalence rates (per 1000 women) were calculated for short- and long-acting methods to investigate changes over time. Poisson's regression was used to (1) test whether the abortion rate changed by year; (2) whether 2010 (when the contraceptive implant became subsidized) was a significant point of change; and (3) test the relationship between declining abortions and patterns of contraceptive use. Results: Estimated LARC prevalence increased from 2009 to 2014, with a corresponding decrease observed in prescription of short-acting methods. The declining abortion rate accelerated each year from 2008 to 2014 (with a faster decline from 2010 to 2014), but 2010 was not a significant point of change. Three factors had statistically significant associations with declining abortion rates (p < 0.01): year (acting as a surrogate for all social changes), women's use of the levonorgestrel (LNG)-implant, and the combined model: use of the LNG-implant and copper intrauterine device (CuIUD) had the best fit (using Akaike's Information Criterion), indicating that this variable explained more of the year-to-year variability in abortion rates. Conclusions: The shift toward women's increased use of the two publically funded LARC methods (LNG-implants and CuIUD) was significantly associated with the declining abortion rates in New Zealand.
Asunto(s)
Aborto Inducido/estadística & datos numéricos , Anticonceptivos Femeninos/uso terapéutico , Anticoncepción Reversible de Larga Duración/estadística & datos numéricos , Anticoncepción/métodos , Conducta Anticonceptiva/estadística & datos numéricos , Femenino , Humanos , Dispositivos Intrauterinos de Cobre/estadística & datos numéricos , Levonorgestrel/uso terapéutico , Nueva Zelanda/epidemiologíaRESUMEN
Purpose: This study aimed to explore the prescription of different contraceptive methods to Swedish women with obesity and to compare the pattern of prescription and adherence to treatment between this group and normal-weight women. Materials and methods: This study included 371 women with obesity and 744 matched normal-weight women, aged 18-40. Medical records were scrutinised for the period 1 January 2010 to 31 December 2014. The retrieved variables included: background characteristics, prescribed contraceptive methods, adverse effects, duration of treatment, reason for discontinuation and bleeding pattern. Result: Progestin-only pills were mainly prescribed to women with obesity (44% vs. 20%, p = 0.001) whereas combined hormonal contraception was mainly prescribed to normal-weight women (60% vs. 21%, p < 0.0001). Thirty-three percent vs. 25% (p = 0.003) discontinued their contraceptive method within 1 year. The most commonly declared reason for discontinuation was bleeding disturbance (14.7% vs. 9.6%, p = 0.008). Conclusion: The most commonly prescribed contraceptive method in women with obesity was progestin-only pills, but surprisingly many women with obesity were prescribed combined hormonal contraception despite current Swedish and European guidelines. Incident users with obesity were significantly more likely to discontinue their contraceptive method within the first year of the study period, compared with incident normal-weight users.
Asunto(s)
Anticonceptivos Orales Combinados , Anticonceptivos Hormonales Orales , Prescripciones de Medicamentos/estadística & datos numéricos , Peso Corporal Ideal , Cumplimiento de la Medicación/estadística & datos numéricos , Obesidad , Adolescente , Adulto , Anticoncepción/métodos , Anticonceptivos Orales Combinados/efectos adversos , Anticonceptivos Hormonales Orales/efectos adversos , Femenino , Humanos , Dispositivos Intrauterinos de Cobre/estadística & datos numéricos , Acetato de Medroxiprogesterona , Trastornos de la Menstruación/inducido químicamente , Obesidad/complicaciones , Guías de Práctica Clínica como Asunto , Progestinas/efectos adversos , Estudios Retrospectivos , Suecia , Adulto JovenRESUMEN
OBJECTIVES: To estimate uptake of long-acting reversible contraception (LARC) methods immediately after surgical abortion in a system that makes these methods readily available, and to determine demographic, medical, social, and visit-specific predictors of immediate post-abortion intrauterine device (IUD) and implant initiation. STUDY DESIGN: We performed a retrospective cohort study of LARC (levonorgestrel intrauterine system [IUS], copper IUD, and subdermal implant) initiation at the time of surgical abortion up to 21w0d gestation at Planned Parenthood League of Massachusetts from 2012 through 2017. We calculated proportions of IUD and implant initiation and used mixed effect logistic regression to estimate predictors of each outcome. RESULTS: Among 26,858 surgical abortion patients, 25.4% received immediate post-abortion LARC: 14.2%, 4.2%, and 7.0% received a levonorgestrel IUS, copper IUD, and implant, respectively. Compared to White women, Black women had lower odds of initiating an IUD (aOR 0.81, 95% CI 0.74-0.89). Multiparous women had greater odds than nulliparous women of initiating an IUD (aOR 1.69, 95% CI 1.57-1.82) or implant (aOR 1.36, 95% 1.20-1.53). We found age was the strongest predictor of implant initiation (<18 versus≥35: aOR 3.26, 95% CI 2.26-4.71), but was not associated with IUD uptake. Gestational age was not associated with IUD or implant uptake. Implant uptake increased from 2.4% (2012) to 8.7% (2017) (aOR 3.65, 95% CI 2.36-5.65) while IUD uptake remained fairly constant. CONCLUSION: About 25% of women chose to initiate intrauterine or implantable contraception immediately after surgical abortion when these methods are readily available. Implant uptake has increased significantly in recent years. Women who initiated IUDs and implants differed in their demographic and social profiles. IMPLICATIONS: Women seeking surgical abortion should have same-day access to IUDs and implants. Clinicians and researchers should analyze IUD and implant initiation separately.
Asunto(s)
Aborto Inducido/estadística & datos numéricos , Dispositivos Intrauterinos de Cobre/estadística & datos numéricos , Dispositivos Intrauterinos Medicados/estadística & datos numéricos , Anticoncepción Reversible de Larga Duración/instrumentación , Anticoncepción Reversible de Larga Duración/estadística & datos numéricos , Adolescente , Adulto , Femenino , Humanos , Levonorgestrel/administración & dosificación , Modelos Logísticos , Massachusetts , Embarazo , Prevalencia , Estudios Retrospectivos , Adulto JovenRESUMEN
Abstract Objective To compare sexual function and quality of life (QOL) among intrauterine contraceptive (copper-intrauterine device [Cu-IUD] or the 52-mg 20 μg/day levonorgestrel- releasing intrauterine system [LNG-IUS]) users. Methods This was part of a cross-sectional study. Women aged between 18 and 49 years old, in a heterosexual relationship, reporting sexual intercourse in the previous 4 weeks, using Cu-IUD (Group 1) or LNG-IUS (Group 2) responded to a questionnaire with sociodemographic information, to the Female Sexual Function Index (FSFI), to the World Health Organization QOL Questionnaire Abbreviated Version (WHOQOL-BREF), and to a questionnaire about the contraceptive method used. The Student t-test, the Pearson χ2 test or the Fisher exact test, and the Mann-Whitney test were used for the analysis. For the adjusted comparison, we have used the analysis of covariance (ANCOVA). A multiple regression analyzing factors related to FSFI 26.55 was done. Significance was established at p < 0.05. Results A total of 347 women in Group 1 (mean age of 32.3 ± 7.5 years old) and of 298 in Group 2 (mean age of 32.7 ± 6.4 years old) completed the questionnaires.Most women had ≥ 8 years of schooling, were in amonogamous relationship, and had had ≤ 2 pregnancies. A total of 122 Cu-IUD and of 87 LNG-IUS users scored ≤ 26.55 on the FSFI. Significant lower scores in physical, environmental, and overall QOL domains in the WHOQOL-BREF questionnaire were found in Group 1. More women using the Cu- IUD were not satisfied with the method. Conclusion We did not find significant differences in sexual function; there was a lower score in some domains of QOL among women who used the Cu-IUD. It was not possible to ensure that those differences were related to the contraceptive method.
Resumo Objetivo Comparar a função sexual e a qualidade de vida (QV) entre usuárias de contraceptivos intrauterinos (dispositivo intrauterino com cobre [DIU-cobre] ou sistema intrauterino liberador de levonorgestrel [SIU-LNG 52 mg 20 μg/dia]. Métodos O presente estudo foi parte de um estudo de corte transversal. Mulheres com idades entre 18 e 49 anos, em relacionamento heterossexual, relatando relação sexual nas 4 semanas anteriores, utilizando DIU-cobre (Grupo 1) ou SIU-LNG (Grupo 2) responderam ao questionário com informações sociodemográficas, ao Índice de Função Sexual Feminino (IFSF), ao Questionário de QV da Organização Mundial de Saúde, versão abreviada (WHOQOL-BREF, na sigla eminglês), e a umquestionário sobre ométodo contraceptivo utilizado criado para o presente estudo. Os testes t de Student, o teste χ2 de Pearson, o teste exato de Fisher e o teste de Mann-Whitney foram utilizados. A análise de covariância (ANCOVA) foi utilizada para a comparação ajustada. Foi realizada a análise de regressão logística multivariada analisando fatores associados ao IFSF ≤ 26.55. O nível de significância foi p < 0.05. Resultados Um total de 347 mulheres no Grupo 1 (idade média 32,3 ± 7,5 anos) e de 298 no Grupo 2 (idade média 32,7 ± 6,4 anos) completaram os questionários. A maioria das mulheres relatou ≥ 8 anos de escolaridade, estava emrelaçãomonogâmica e teve ≤ 2 gestações. Um total de 122 e de 87 usuárias do DIU-cobre e do SIU-LNG, respectivamente, pontuaram ≤ 26,55 no IFSF. Pontuações significativamente menores nos domínios físico, meio-ambiente e QV geral no WHOQOL-BREF foram encontrados no Grupo 1. Mais mulheres do Grupo 1 estavam insatisfeitas com o método. Conclusão Não encontramos diferenças na função sexual, entretanto havia menores pontuações em certos domínios da QV entre as usuárias do DIU-cobre. Não foi possível afirmar relação dessas diferenças com os métodos.
Asunto(s)
Humanos , Femenino , Adolescente , Adulto , Adulto Joven , Calidad de Vida , Conducta Sexual , Dispositivos Intrauterinos/estadística & datos numéricos , Brasil , Estudios Transversales , Encuestas y Cuestionarios , Estudios de Cohortes , Levonorgestrel , Dispositivos Intrauterinos Medicados/estadística & datos numéricos , Dispositivos Intrauterinos de Cobre/estadística & datos numéricos , Persona de Mediana EdadRESUMEN
OBJECTIVE: To compare sexual function and quality of life (QOL) among intrauterine contraceptive (copper-intrauterine device [Cu-IUD] or the 52-mg 20 µg/day levonorgestrel-releasing intrauterine system [LNG-IUS]) users. METHODS: This was part of a cross-sectional study. Women aged between 18 and 49 years old, in a heterosexual relationship, reporting sexual intercourse in the previous 4 weeks, using Cu-IUD (Group 1) or LNG-IUS (Group 2) responded to a questionnaire with sociodemographic information, to the Female Sexual Function Index (FSFI), to the World Health Organization QOL Questionnaire Abbreviated Version (WHOQOL-BREF), and to a questionnaire about the contraceptive method used. The Student t-test, the Pearson χ2 test or the Fisher exact test, and the Mann-Whitney test were used for the analysis. For the adjusted comparison, we have used the analysis of covariance (ANCOVA). A multiple regression analyzing factors related to FSFI ≤ 26.55 was done. Significance was established at p < 0.05. RESULTS: A total of 347 women in Group 1 (mean age of 32.3 ± 7.5 years old) and of 298 in Group 2 (mean age of 32.7 ± 6.4 years old) completed the questionnaires. Most women had ≥ 8 years of schooling, were in a monogamous relationship, and had had ≤ 2 pregnancies. A total of 122 Cu-IUD and of 87 LNG-IUS users scored ≤ 26.55 on the FSFI. Significant lower scores in physical, environmental, and overall QOL domains in the WHOQOL-BREF questionnaire were found in Group 1. More women using the Cu-IUD were not satisfied with the method. CONCLUSION: We did not find significant differences in sexual function; there was a lower score in some domains of QOL among women who used the Cu-IUD. It was not possible to ensure that those differences were related to the contraceptive method.
OBJETIVO: Comparar a função sexual e a qualidade de vida (QV) entre usuárias de contraceptivos intrauterinos (dispositivo intrauterino com cobre [DIU-cobre] ou sistema intrauterino liberador de levonorgestrel [SIU-LNG 52 mg 20 µg/dia]. MéTODOS: O presente estudo foi parte de um estudo de corte transversal. Mulheres com idades entre 18 e 49 anos, em relacionamento heterossexual, relatando relação sexual nas 4 semanas anteriores, utilizando DIU-cobre (Grupo 1) ou SIU-LNG (Grupo 2) responderam ao questionário com informações sociodemográficas, ao Índice de Função Sexual Feminino (IFSF), ao Questionário de QV da Organização Mundial de Saúde, versão abreviada (WHOQOL-BREF, na sigla em inglês), e a um questionário sobre o método contraceptivo utilizado criado para o presente estudo. Os testes t de Student, o teste χ2 de Pearson, o teste exato de Fisher e o teste de Mann-Whitney foram utilizados. A análise de covariância (ANCOVA) foi utilizada para a comparação ajustada. Foi realizada a análise de regressão logística multivariada analisando fatores associados ao IFSF ≤ 26.55. O nível de significância foi p < 0.05. RESULTADOS: Um total de 347 mulheres no Grupo 1 (idade média 32,3 ± 7,5 anos) e de 298 no Grupo 2 (idade média 32,7 ± 6,4 anos) completaram os questionários. A maioria das mulheres relatou ≥ 8 anos de escolaridade, estava em relação monogâmica e teve ≤ 2 gestações. Um total de 122 e de 87 usuárias do DIU-cobre e do SIU-LNG, respectivamente, pontuaram ≤ 26,55 no IFSF. Pontuações significativamente menores nos domínios físico, meio-ambiente e QV geral no WHOQOL-BREF foram encontrados no Grupo 1. Mais mulheres do Grupo 1 estavam insatisfeitas com o método. CONCLUSãO: Não encontramos diferenças na função sexual, entretanto havia menores pontuações em certos domínios da QV entre as usuárias do DIU-cobre. Não foi possível afirmar relação dessas diferenças com os métodos.